Brand & Product Security

Antipsychotic and antidepressant drugs have risen to the top categories of prescribed medications in a challenging and risky medical and regulatory arena

States continue to push for a ‘bio-economic’ foundation

States continue to push for a ‘bio-economic’ foundation

Drugmakers recalibrate anti-counterfeiting and serialization efforts

Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment

Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services